Creo Medical Group Management
Management criteria checks 2/4
Creo Medical Group's CEO is Craig Gulliford, appointed in Jan 2012, has a tenure of 12.83 years. total yearly compensation is £881.66K, comprised of 34.6% salary and 65.4% bonuses, including company stock and options. directly owns 0.41% of the company’s shares, worth €360.27K. The average tenure of the management team and the board of directors is 8.3 years and 6.4 years respectively.
Key information
Craig Gulliford
Chief executive officer
UK£881.7k
Total compensation
| CEO salary percentage | 34.6% |
| CEO tenure | 12.8yrs |
| CEO ownership | 0.4% |
| Management average tenure | 8.3yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -UK£22m |
| Mar 31 2024 | n/a | n/a | -UK£22m |
| Dec 31 2023 | UK£882k | UK£305k | -UK£22m |
| Sep 30 2023 | n/a | n/a | -UK£23m |
| Jun 30 2023 | n/a | n/a | -UK£25m |
| Mar 31 2023 | n/a | n/a | -UK£26m |
| Dec 31 2022 | UK£677k | UK£280k | -UK£27m |
| Sep 30 2022 | n/a | n/a | -UK£28m |
| Jun 30 2022 | n/a | n/a | -UK£28m |
| Mar 31 2022 | n/a | n/a | -UK£26m |
| Dec 31 2021 | UK£1m | UK£280k | -UK£25m |
| Sep 30 2021 | n/a | n/a | -UK£23m |
| Jun 30 2021 | n/a | n/a | -UK£21m |
| Mar 31 2021 | n/a | n/a | -UK£21m |
| Dec 31 2020 | UK£949k | UK£280k | -UK£20m |
| Sep 30 2020 | n/a | n/a | -UK£19m |
| Jun 30 2020 | n/a | n/a | -UK£17m |
| Mar 31 2020 | n/a | n/a | -UK£17m |
| Dec 31 2019 | UK£1m | UK£675k | -UK£16m |
| Jun 30 2019 | n/a | n/a | -UK£13m |
| Mar 31 2019 | n/a | n/a | -UK£12m |
| Dec 31 2018 | UK£1m | UK£792k | -UK£10m |
Compensation vs Market: Craig's total compensation ($USD1.12M) is above average for companies of similar size in the German market ($USD480.14K).
Compensation vs Earnings: Craig's compensation has increased whilst the company is unprofitable.
CEO
Craig Gulliford (54 yo)
12.8yrs
Tenure
UK£881,657
Compensation
Mr. Craig Jonathan Gulliford serves as the Chief Executive Officer of Creo Medical Group plc since 2012. Mr. Gulliford served as Operations Director of Vix ACIS Limited (formerly ACIS Holdings Ltd). Mr. G...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 12.8yrs | UK£881.66k | 0.41% € 360.3k | |
| Founder | 22.8yrs | UK£647.22k | 1.2% € 1.1m | |
| CFO & Executive Director | 8.3yrs | UK£650.61k | 0.76% € 665.2k | |
| Chief Commercial Officer & Executive Director | 4.3yrs | UK£664.76k | 0.11% € 96.5k | |
| Sales & Marketing Director | no data | no data | no data | |
| Secretary | less than a year | no data | no data |
8.3yrs
Average Tenure
55.5yo
Average Age
Experienced Management: 1RC's management team is seasoned and experienced (8.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 8.2yrs | UK£881.66k | 0.41% € 360.3k | |
| Founder | 8.2yrs | UK£647.22k | 1.2% € 1.1m | |
| CFO & Executive Director | 8.3yrs | UK£650.61k | 0.76% € 665.2k | |
| Chief Commercial Officer & Executive Director | 8yrs | UK£664.76k | 0.11% € 96.5k | |
| Chairman | less than a year | no data | 0.89% € 781.4k | |
| Senior Independent Non-Executive Director | 3yrs | UK£56.00k | 0.34% € 300.4k | |
| Independent Non-Executive Director | 4.8yrs | UK£56.00k | 0.031% € 27.4k | |
| Independent Non-Executive Director | less than a year | no data | no data |
6.4yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 1RC's board of directors are considered experienced (6.4 years average tenure).